Diacomit

Diacomit contains 250 mg stiripentol

• 

In December 2001 the European Medicines Agency (EMA) granted stiripentol orphan drug status (designation number EU/3/01/071) for the treatment of severe myoclonic epilepsy of infancy (Dravet's syndrome). On 4 January 2007, the EMA granted the drug a marketing authorisation that is valid throughout the European Union

Dravet Syndrome does not exist data

atc

http://www.whocc.no/atc_ddd_index/?code=N03AX17